Onconetix (ONCO) Enterprise Value (2021 - 2026)
Onconetix (ONCO) posted quarterly Enterprise Value of -$3.7 million for Q1 2026, down 135.61% year-over-year from $10.4 million in Q1 2025, and up 28.82% quarter-over-quarter from -$5.2 million in Q4 2025.
Onconetix (ONCO) Enterprise Value (2021 - 2026) Analysis & Trends
Onconetix (ONCO) has reported Enterprise Value for 6 consecutive years, with -$3.7 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Enterprise Value fell 135.61% year-over-year to -$3.7 million; the TTM figure through Mar 2026 stood at -$3.7 million (down 135.61% YoY), while the FY2025 annual figure was -$5.2 million, down 707.53% from the prior year.
- Enterprise Value grew to -$3.7 million in Q1 2026 per ONCO's latest filing, from -$5.2 million in the prior quarter.
- Across five years, Enterprise Value topped out at $6.8 million in Q3 2024 and bottomed at -$29.1 million in Q3 2022.
- Historically, Enterprise Value has averaged -$7.6 million across 5 years, with a median of -$3.7 million in 2026.
- Annual changes were most pronounced in 2022 — Enterprise Value sank 1235.39% — and 2024, when it surged 188.44%.
- Onconetix's Enterprise Value stood at -$25.8 million in 2022, then surged by 109.52% to $2.5 million in 2023, then sank by 126.36% to -$646500.0 in 2024, then sank by 707.53% to -$5.2 million in 2025, then rose by 28.82% to -$3.7 million in 2026.
- Business Quant data shows ONCO's Enterprise Value at -$3.7 million in Q1 2026, -$5.2 million in Q4 2025, and -$836556.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.71 Bn | 131.86 Bn | 2.84 Bn | -7.85 Bn |
| 2 | Regeneron Pharmaceuticals | 86.55 Bn | 78.55 Bn | 3.93 Bn | -7.99 Bn |
| 3 | Argenx Se | 65.26 Bn | 60.07 Bn | 1.37 Bn | -5.18 Bn |
| 4 | Moderna | 59.81 Bn | 54.67 Bn | 52.00 Mn | -5.14 Bn |
| 5 | BeOne Medicines | 42.16 Bn | 37.06 Bn | 1.53 Bn | -5.10 Bn |
| 6 | Alnylam Pharmaceuticals | 31.87 Bn | 28.56 Bn | 992.69 Mn | -3.31 Bn |
| 7 | BioNTech SE | 28.13 Bn | 9.74 Bn | 668.28 Mn | -18.39 Bn |
| 8 | Insmed | 27.53 Bn | 26.37 Bn | 358.27 Mn | -1.16 Bn |
| 9 | Royalty Pharma | 27.31 Bn | 26.47 Bn | - | 2.12 Bn |
| 10 | Onconetix | 1.42 Mn | -4.52 Mn | 4,303.00 | -5.94 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -5.94 Mn |
| Mar 31, 2026 | -3.72 Mn |
| Dec 31, 2025 | -5.22 Mn |
| Sep 30, 2025 | -836,556.00 |
| Jun 30, 2025 | -283,515.00 |
| Mar 31, 2025 | -1.58 Mn |
| Dec 31, 2024 | -646,500.00 |
| Sep 30, 2024 | 6.77 Mn |
| Jun 30, 2024 | 6.15 Mn |
| Mar 31, 2024 | 2.57 Mn |
| Dec 31, 2023 | 2.45 Mn |
| Sep 30, 2023 | -7.65 Mn |
| Jun 30, 2023 | -9.22 Mn |
| Mar 31, 2023 | -22.26 Mn |
| Dec 31, 2022 | -25.75 Mn |
| Sep 30, 2022 | -29.14 Mn |
| Jun 30, 2022 | -22.24 Mn |
| Mar 31, 2022 | -18.61 Mn |
| Dec 31, 2021 | -1.93 Mn |